Swedencare () : Swedencare förvärvar amerikanska Vetio
July 30, 2021
Share
Swedencare acquires US-based Vetio
1 July 2021
Expanding Swedencare's reach in the dynamic Animal Health (AH) market
Vetio Animal Health: North America's premiere CDMO dedicated exclusively to the global Animal Health industry
Vetio's Vision is to become the leading global CDMO in Animal Health
Staying true to our Mission
Delivering our Value Proposition
Vetio's Mission
The development and manufacturing of products that improve the lives of animals, while ensuring the safety, quality, and compliance of the products to the highest industry standards.
Actualizing Animal Health
As a Contract Development and Manufacturing Organization (CDMO) dedicated to Animal Health, we integrate product development with full-scale manufacturing through a Quality by Design-based process. Vetio is your single-source partner for successful product approval, commercialization, and ongoing supply.
Four pillars of service from pre-formulation through commercial manufacturing
Product Development
Technical Services
Analytical Services
Contract Manufacturing
Pharmaceutical Development & Manufacturing Montreal, QC, Canada
Product
Development
Technical
Services
Vetio North
Analytical
Services
Contract
Manufacturing
Veterinary Drug Development and Manufacturing, solid dose and non-sterile liquids
Analytical Services
Stability (7 reach-in and 3 walk-in chambers)
Method development & Release testing
45k sq. ft. facility with 40 employees
Global Leader in OTC Liquid Topicals Jupiter, FL, USA
Product
Development
Vetio South
Contract
Manufacturing
Development and manufacturing of OTC dermatology liquids and liquid supplements
Experienced in-house product and analytical development including micro and stability
40k sq. ft. manufacturing facility with 110 employees producing >14M units annually
Favorable industry dynamics creating increased demand for Animal Health Drug Development & Manufacturing
Favorable Tailwinds
Increased # of pet adoptions and continued pet humanization trend
Top 20 Animal Health firms CAGRs 5-10%
Growth across all channels (Vet clinics and Online/DTC)
Relatively low market share of generic drugs
M&A leading to reshuffling of product portfolios
Greater R&D Spending
R&D spending as much as 10% of sales at several Animal Health firms
Attractive returns on investment to build files
Both pioneer and generic drugs
Dry Powder available for investors to enter the market
Unmet therapeutic needs (often where there is a human drug for cross-over)
Why Vetio
Outsourcing Trend to CDMOs
Established track record of developing both innovative & generic drugs through agency approval
One of the only true CDMOs dedicated to Animal Health
Capabilities, Compliance, and Concentration on Animal Health
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Swedencare AB published this content on 01 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2021 15:43:03 UTC.
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
SWEDENCARE AB 
